<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27920420</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1941-5923</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><PubDate><Year>2016</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>The American journal of case reports</Title><ISOAbbreviation>Am J Case Rep</ISOAbbreviation></Journal><ArticleTitle>Treatment Effectiveness of Amantadine Against Dengue Virus Infection.</ArticleTitle><Pagination><StartPage>921</StartPage><EndPage>924</EndPage><MedlinePgn>921-924</MedlinePgn></Pagination><Abstract><AbstractText>BACKGROUND About 400 million cases of dengue, a mosquito-borne disease, are reported annually, but no drug is yet available for treatment. In 1988, at Feng Lin Clinic, Taiwan, we encountered about 10,000 cases and tested various drugs before confirming an antiviral effect of amantadine against dengue virus in vitro. After we administered amantadine to patients for 1-2 days, most achieved full remission. None experienced potentially life-threatening dengue hemorrhagic fever or dengue shock syndrome. Herein, we present 34 cases from recent clinical experience that show amantadine's unusual effect against dengue virus infection. CASE REPORT We divided 34 patients with symptoms of dengue fever, confirmed by a screening test, into 3 groups: 6 Category 1 patients received amantadine at onset, 21 Category 2 patients received amantadine within 2-6 days, and 7 Contrast group patients received no amantadine because they visited other clinics or were admitted to a large hospital. When Category 1 patients were treated with amantadine 100 mg 3 times per day, all symptoms dramatically subsided within 1-2 days. In Category 2 patients, most symptoms diminished within 1-2 days after starting the same regimen. In the Contrast group, all symptoms persisted 7 days after onset. White blood cell and platelet counts in Category 1 and 2 patients recovered to normal range, but remained below low normal in the Contrast group. CONCLUSIONS Amantadine is effective and should be given as soon as possible to stop the disease course if dengue fever is confirmed through screening or clinical signs and symptoms. A well-designed larger sample study is warranted to test this effectiveness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chieh-Cheng</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Feng Lin Clinic, Ding Sang Clinic, and Kung Feng Clinic, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wen-Ching</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Feng Lin Clinic, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Case Rep</MedlineTA><NlmUniqueID>101489566</NlmUniqueID><ISSNLinking>1941-5923</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>BF4C9Z1J53</RegistryNumber><NameOfSubstance UI="D000547">Amantadine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000547" MajorTopicYN="N">Amantadine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009033" MajorTopicYN="N">Culicidae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amantadine</Keyword><Keyword MajorTopicYN="N">Dengue Virus</Keyword><Keyword MajorTopicYN="N">Treatment Outcome</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27920420</ArticleId><ArticleId IdType="pmc">PMC5158130</ArticleId><ArticleId IdType="doi">10.12659/AJCR.901014</ArticleId><ArticleId IdType="pii">901014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention  Dengue.  [updated 2016 Jan 19; cited 2016 Aug 2]. Available from:  https://www.cdc.gov/dengue.</Citation></Reference><Reference><Citation>World Health Organization  Dengue.  [cited 2016 Aug 2]. Available from:  http://www.who.int/topics/dengue/en.</Citation></Reference><Reference><Citation>Davies WL, Grunert RR, Haff RF, et al. Antiviral activity of 1-adamantanamine (amantadine) Science. 1964;144:862&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">14151624</ArticleId></ArticleIdList></Reference><Reference><Citation>Koff WC, Elm JL, Halstead SB. Inhibition of dengue virus replication by amantadine hydrochloride. Antimicrob Agents Chemother. 1980;18(1):125&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC283951</ArticleId><ArticleId IdType="pubmed">7416739</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control, R.O.C. (Taiwan)  As dengue outbreak in Kaohsiung City yet to abate, CECC for Dengue Outbreak continues to provide full support to Kaohsiung City to help bring outbreak under control as soon as possible. 2015. Nov 21,  [cited 2016 Jun 8]. Available from:  http://www.cdc.gov.tw/english/info.aspx?treeid=bc2d4e89b154059b&amp;nowtreeid=ee0a2987cfba3222&amp;tid=57C3974A3818E7FC.</Citation></Reference><Reference><Citation>Nicholson KG, Wiselka MJ. Amantadine for influenza A. BMJ. 1991;302:425&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1669349</ArticleId><ArticleId IdType="pubmed">2004163</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabey JM, Nissipeanu P, Korczyn AD. Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson&#x2019;s disease. J Neural Transm Park Dis Dement Sect. 1992;4:277&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">1388698</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd SM, Hinfey PB, Shoff WH. Dengue treatment &amp; management.  Medscape [updated 2015 Oct 5; cited 2016 Aug 2]. Available from:  http://emedicine.medscape.com/article/215840-treatment.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention  Influenza antiviral drug resistance.  [cited 2016 Aug 2]. Available from:  http://www.cdc.gov/flu/about/qa/antiviralresistance.htm.</Citation></Reference><Reference><Citation>Cunha JP. Symmetrel FDA prescribing information: side effects (adverse reactions)  [cited 2016 Aug 3]. Available from:  http://www.rxlist.com/symmetrel-side-effects-drug-center.htm.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>